EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Growth differentiation factor 15 mitigates lipotoxic steatosis by preserving mitochondrial morphodynamics and augmenting fatty acid oxidation in hepatocytes and liver organoids

Jia Li iD, Qi Zhou, Mengmeng Xia, Yakun Li, Junyu Wang, Manon Buist-Homan, Vincent E de Meijer iD, Hans Blokzijl, Klaas Nico Faber, Han Moshage

Diabetes, Obesity and Metabolism · 2026-05 · 28 (5) · 3788-3806

DOI: 10.1111/dom.70561 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, online erschienen am 19.02.2026. Verfasst von Jia Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. Hauptthemen laut MEDLINE: Hepatocytes, Growth Differentiation Factor 15, Fatty Acids, Liver. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Chinese Government Scholarship, Stichting De Cock-Hadders.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Growth differentiation factor 15 (GDF15) has emerged as a promising metabolic regulator with hepatoprotective properties in metabolic dysfunction‐associated steatotic liver disease (MASLD), yet its underlying mechanisms remain elusive. Given that mitochondria are the primary site of fatty acid oxidation (FAO) and that mitochondrial morphodynamics are critical for normal hepatic lipid metabolism, we investigated how GDF15 regulates hepatic lipid homeostasis through mitochondrial dynamics. Materials and Methods We established cellular steatosis models using primary rat hepatocytes exposed to lipotoxic palmitate (PA) or non‐lipotoxic free fatty acid mixture (FFA, oleate: palmitate = 2: 1). Following GDF15 administration, we quantified lipid droplet content, expression of lipid metabolism genes, mitochondrial fatty acid translocation, and mitochondrial morphodynamics and function. The mechanistic role of ERK1/2 signalling was assessed through pharmacological inhibition. These findings were subsequently validated in adult progenitor cell‐derived human liver organoids.

Results

GDF15 significantly mitigated both PA‐ and FFA‐induced lipid accumulation by upregulating key FAO genes and down regulating lipid synthesis genes. Importantly, GDF15 corrected PA‐induced mitochondrial fusion‐fission imbalance by increasing mitochondrial fusion proteins MFN1 and OPA1 while modulating the activation of fission regulator DRP1. GDF15 enhanced fatty acid translocation into mitochondria and improved FAO. Mechanistically, GDF15 exerted these effects partially through inhibition of the ERK1/2 signalling pathway. Human liver organoid models further corroborated this protective mechanism of GDF15 against hepatic steatosis.

Conclusions

Our study reveals that, specifically under lipotoxic conditions, GDF15 alleviates hepatocyte steatosis by preserving mitochondrial morphodynamics homeostasis and enhancing mitochondrial FAO capacity via ERK1/2 inhibition. These condition‐specific mechanisms provide critical insights into GDF15's hepatoprotective effects and support its further investigation as a potential therapeutic target for MASLD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HepatocytesGrowth Differentiation Factor 15Fatty AcidsLiverOrganoidsFatty LiverMitochondria, LiverAnimalsHumansRatsOxidation-ReductionLipid MetabolismMaleCells, CulturedMitochondrial DynamicsMAP Kinase Signaling System

Stichwörter der Autor:innen

GDF15MASLDlipid metabolismmitochondrial morphodynamics

Substanzen

Growth Differentiation Factor 15Fatty Acids

Autor:innen und Institutionen

  • Department of Gastroenterology and Hepatology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • Department of Stem Cell Research Center, Shantou University Medical College, Shantou, Guangdong, China.
  • Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • Department of Surgery, Division of Hepato-Pancreato-Biliary Surgery and Liver Transplantation, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

ORCID-Profile: Jia Li, Vincent E de Meijer

Förderung

  • Chinese Government Scholarship
  • Stichting De Cock-Hadders

Zitieren

APA

Li, J., Zhou, Q., Xia, M., Li, Y., Wang, J., Buist-Homan, M., de Meijer, V. E., Blokzijl, H., Faber, K. N., & Moshage, H. (2026). Growth differentiation factor 15 mitigates lipotoxic steatosis by preserving mitochondrial morphodynamics and augmenting fatty acid oxidation in hepatocytes and liver organoids. Diabetes, Obesity and Metabolism, 28(5), 3788-3806. https://doi.org/10.1111/dom.70561

Vancouver

Li J, Zhou Q, Xia M, Li Y, Wang J, Buist-Homan M, et al. Growth differentiation factor 15 mitigates lipotoxic steatosis by preserving mitochondrial morphodynamics and augmenting fatty acid oxidation in hepatocytes and liver organoids. Diabetes, Obesity and Metabolism. 2026;28(5):3788-3806. doi:10.1111/dom.70561

BibTeX
@article{Li2026,
  author = {Li, Jia and Zhou, Qi and Xia, Mengmeng and Li, Yakun and Wang, Junyu and Buist-Homan, Manon and de Meijer, Vincent E and Blokzijl, Hans and Faber, Klaas Nico and Moshage, Han},
  title = {Growth differentiation factor 15 mitigates lipotoxic steatosis by preserving mitochondrial morphodynamics and augmenting fatty acid oxidation in hepatocytes and liver organoids},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2026},
  volume = {28},
  number = {5},
  pages = {3788--3806},
  doi = {10.1111/dom.70561}
}
Kostenlos starten →